with a market valuation of 22,006.03 crores, IPCA Laboratories Limited is a large-cap business that operates in the pharmaceutical industry. The pharmaceutical business IPCA produces more than 350 formulations and 80 APIs for a range of pharmacological fields. With manufacturing leadership in over 12 APIs, the firm is one of the largest suppliers of these APIs globally. Today, the company announced its Q2 financial results and a 400% dividend to its eligible shareholders.
The company in a stock exchange filing today said that “We would like to inform you that, the Board has declared an interim dividend of Rs. 4/- per share (400%) for the financial year 2022-23. Please note That vide our letter dated November 2, 2022, we have already informed you that November 23, 2022 has been fixed as the record date to ensure the eligibility of the members of the said interim dividend, to be paid by the Company. to the eligible people by the shareholders on or before December 7, 2022.”
For Q2FY23 and on a standalone basis, the company declared net sales of 1484.88 crore as compared to Q2FY22 and . 1423.84 crore in 1469.28 Crores were posted in Q1FY23 which represents a year-on-year growth of 4.28% and QoQ growth of 1.06%. The company’s net profit declined by 34.88% year-on-year 167.78 crore in Q2FY23 from 257.64 Crore Posted in Q2FY22 & Net Profit on QoQ basis climbed by 16.65% 143.82 crore were posted in the quarter ended June 2022. eps was Compared to 6.61 per share in Q2FY23 5.67 more in Q1FY23 10.16 in Q2FY22.
On a consolidated basis, the Company declared revenue from operations of Compared to 1600.95 cr in Q2FY23 Q2FY22 and . 1544.43 crore in 1585.74 crore in Q1FY23, representing a year-on-year growth of 3.65% and QoQ growth of 0.95%. The company declared net profit of 143.90 crore in Q2FY23 as compared to 143.06 crore in Q1FY23 and 250.23 crore in Q2FY22, representing a year-on-year decline of 42.49% and QoQ growth of 0.58%. stood on eps Compared to 5.67 per share in Q2FY23 5.64 more in Q1FY23 9.66 Posted in Q2FY22.
Shares of IPCA Laboratories Ltd closed today 865.00 each, down 2.63% from previous close 888.35. In trading today the stock recorded a total volume of 782,521 shares compared to the 20-day average volume of 220,772 shares. On NSE, the stock had touched a 52-week high 52-week low of 1,128.50 on (10-Jan-2022) and On 831.05 (13-Jun-2022), it shows that the stock is trading 23.34% below the high and 4.08% above the low at the current market price. For the quarter ended September or Q2FY23, the company reported promoter shareholding of 46.29%, FII’s stake of 10.57%, DII’s stake of 33.46%, Government stake of 0.32% and Public stake of 9.34%.
catch all business News, market news, today’s fresh news events and breaking news Updates on Live Mint. download mint news app To get daily market updates.